Cargando…
Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer
A substantial fraction of early-stage triple-negative breast cancer (eTNBC) is characterized by high levels of stromal tumor-infiltrating lymphocytes (sTIL) and has a good prognosis even without systemic treatment, highlighting the importance of an endogenous anticancer immune response. Still, a con...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320476/ https://www.ncbi.nlm.nih.gov/pubmed/36622327 http://dx.doi.org/10.1158/1078-0432.CCR-22-0701 |